Clinical Trial Update: Rituximab Versus Mycophenolate Mofetil in Children With Steroid-dependent Idiopathic Nephrotic Syndrome. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing rituximab to mycophenolate mofetil in children with steroid-dependent nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Rituximab (rituximab)

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Nephrotic Syndrome Steroid-Dependent | Phase 2 | Status: UNKNOWN